Change Language

Select Language

Press Release:

Global Drug-Eluting Stents Market to Reach US$ 10.8 Billion by 2027, Impelled by Rising Prevalence of Coronary Heart Diseases

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Drug-Eluting Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global drug-eluting stents market reached a value of US$ 7.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 10.8 Billion by 2027, exhibiting at a CAGR of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

A drug-eluting stent (DES) is a coronary device that is used for the slow release of drugs in peripheral or coronary arteries to block cell proliferation and promote a healthy flow of blood. It consists of a metallic stent, polymer coating and anti-restenosis drug. The stent is coated with medications that assist the arteries to remain smooth and ensure adequate blood flow. DES is widely used to treat blockages in heart arteries, prevent plaque buildup, blood clots and reduce repeated revascularization. The stent is minimally invasive (MI) and offers lower restenosis rates, enhanced vessel healing and reduced need for prolonged dual antiplatelet therapy.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Drug-Eluting Stents Market Trends:

The rising geriatric population prone to chronic medical ailments is one of the key factors driving the growth of the market. DES is widely utilized in patients with a high risk of developing arterial disorders as the stents aid in reducing the need for invasive procedures, such as coronary artery bypass surgeries. Additionally, the increasing prevalence of cardiovascular diseases due to the unhealthy dietary patterns, lack of physical activity and sedentary lifestyles of the masses is favoring the market growth. Moreover, various technological advancements, such as the launch of bioresorbable stents, are providing a thrust to the market growth. These stents are easily dissolvable in the body and reduce the risk of developing stent thrombosis. In line with this, the widespread adoption of stents with polymer-free coatings is positively impacting the market growth. These stents exhibit a higher drug loading capacity and quicker drug-eluting rate. Other factors, including the rising incidence of abnormal heart rhythms, heart failure and heart attack disease, along with the increasing demand for MI techniques among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global drug-eluting stents market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on coating, drug, stent platform, generation, application and end user.

Breakup by Coating:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Polymer Based Coating
  • Polymer Free Coating
     

Breakup by Drug:

  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Others
     

Breakup by Stent Platform:

  • Stainless-steel
  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Others
     

Breakup by Generation:

  • 1st Generation
  • 2nd Generation
  • 3rd Generation
  • 4th Generation
     

Breakup by Application:

  • Coronary Artery Disease
  • Peripheral Artery Disease
     

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Coating, Drug, Stent Platform, Generation, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group Ltd., Biotronik, Boston Scientific Corporation, Cardinal Health Inc., Cook Medical LLC (Cook Group Incorporated), Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, MicroPort Scientific Corporation, Sino Medical Sciences Technology Inc. and Terumo Corporation.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global drug-eluting stents market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug-eluting stents market?
  • What are the key regional markets?
  • What is the breakup of the market based on the coating?
  • What is the breakup of the market based on the drug?
  • What is the breakup of the market based on the stent platform?
  • What is the breakup of the market based on the generation?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug-eluting stents market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Drug-Eluting Stents Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Coating
    6.1    Polymer Based Coating
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Polymer Free Coating
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Drug
    7.1    Sirolimus
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Paclitaxel
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Zotarolimus
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Everolimus
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Biolimus
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Stent Platform
    8.1    Stainless-steel
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cobalt-Chromium
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Platinum-Chromium
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Nitinol
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Generation
    9.1    1st Generation
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    2nd Generation
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    3rd Generation
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    4th Generation
        9.4.1 Market Trends
        9.4.2 Market Forecast
10    Market Breakup by Application
    10.1    Coronary Artery Disease
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Peripheral Artery Disease
        10.2.1 Market Trends
        10.2.2 Market Forecast
11    Market Breakup by End User
    11.1    Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Ambulatory Surgical Centers
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Others
        11.3.1 Market Trends
        11.3.2 Market Forecast
12    Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia-Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13    SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14    Value Chain Analysis
15    Porters Five Forces Analysis
    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Price Analysis
17    Competitive Landscape
    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    Abbott Laboratories
           17.3.1.1 Company Overview
           17.3.1.2 Product Portfolio
           17.3.1.3 Financials
           17.3.1.4 SWOT Analysis
        17.3.2    B. Braun Melsungen AG
           17.3.2.1 Company Overview
           17.3.2.2 Product Portfolio
           17.3.2.3 SWOT Analysis
        17.3.3    Biosensors International Group Ltd.
           17.3.3.1 Company Overview
           17.3.3.2 Product Portfolio
        17.3.4    Biotronik
           17.3.4.1 Company Overview
           17.3.4.2 Product Portfolio
           17.3.4.3 SWOT Analysis
        17.3.5    Boston Scientific Corporation
           17.3.5.1 Company Overview
           17.3.5.2 Product Portfolio
           17.3.5.3 Financials
           17.3.5.4 SWOT Analysis
        17.3.6    Cardinal Health Inc.
           17.3.6.1 Company Overview
           17.3.6.2 Product Portfolio
           17.3.6.3 Financials
           17.3.6.4 SWOT Analysis
        17.3.7    Cook Medical LLC (Cook Group Incorporated)
           17.3.7.1 Company Overview
           17.3.7.2 Product Portfolio
           17.3.7.3 SWOT Analysis
        17.3.8    Lepu Medical Technology (Beijing) Co. Ltd.
           17.3.8.1 Company Overview
           17.3.8.2 Product Portfolio
           17.3.8.3 Financials
        17.3.9    Medtronic plc
           17.3.9.1 Company Overview
           17.3.9.2 Product Portfolio
           17.3.9.3 Financials
           17.3.9.4 SWOT Analysis
        17.3.10    MicroPort Scientific Corporation
           17.3.10.1 Company Overview
           17.3.10.2 Product Portfolio
        17.3.11    Sino Medical Sciences Technology Inc.
           17.3.11.1 Company Overview
           17.3.11.2 Product Portfolio
        17.3.12    Terumo Corporation
           17.3.12.1 Company Overview
           17.3.12.2 Product Portfolio
           17.3.12.3 Financials
           17.3.12.4 SWOT Analysis

List of Figures

Figure 1: Global: Drug-Eluting Stents Market: Major Drivers and Challenges
Figure 2: Global: Drug-Eluting Stents Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Drug-Eluting Stents Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Drug-Eluting Stents Market: Breakup by Coating (in %), 2021
Figure 5: Global: Drug-Eluting Stents Market: Breakup by Drug (in %), 2021
Figure 6: Global: Drug-Eluting Stents Market: Breakup by Stent Platform (in %), 2021
Figure 7: Global: Drug-Eluting Stents Market: Breakup by Generation (in %), 2021
Figure 8: Global: Drug-Eluting Stents Market: Breakup by Application (in %), 2021
Figure 9: Global: Drug-Eluting Stents Market: Breakup by End User (in %), 2021
Figure 10: Global: Drug-Eluting Stents Market: Breakup by Region (in %), 2021
Figure 11: Global: Drug-Eluting Stents (Polymer Based Coating) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Drug-Eluting Stents (Polymer Based Coating) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Drug-Eluting Stents (Polymer Free Coating) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Drug-Eluting Stents (Polymer Free Coating) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Drug-Eluting Stents (Sirolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Drug-Eluting Stents (Sirolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Drug-Eluting Stents (Paclitaxel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Drug-Eluting Stents (Paclitaxel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Drug-Eluting Stents (Zotarolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Drug-Eluting Stents (Zotarolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Drug-Eluting Stents (Everolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Drug-Eluting Stents (Everolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Drug-Eluting Stents (Biolimus) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Drug-Eluting Stents (Biolimus) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Drug-Eluting Stents (Other Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Drug-Eluting Stents (Other Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Drug-Eluting Stents (Stainless-steel) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Drug-Eluting Stents (Stainless-steel) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Drug-Eluting Stents (Cobalt-Chromium) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Drug-Eluting Stents (Cobalt-Chromium) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Drug-Eluting Stents (Platinum-Chromium) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Drug-Eluting Stents (Platinum-Chromium) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Drug-Eluting Stents (Nitinol) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Drug-Eluting Stents (Nitinol) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Drug-Eluting Stents (Other Stent Platforms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Drug-Eluting Stents (Other Stent Platforms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Drug-Eluting Stents (1st Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Drug-Eluting Stents (1st Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Drug-Eluting Stents (2nd Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Drug-Eluting Stents (2nd Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Drug-Eluting Stents (3rd Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Drug-Eluting Stents (3rd Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Drug-Eluting Stents (4th Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Drug-Eluting Stents (4th Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Drug-Eluting Stents (Coronary Artery Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Drug-Eluting Stents (Coronary Artery Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Drug-Eluting Stents (Peripheral Artery Disease) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Drug-Eluting Stents (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Drug-Eluting Stents (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Global: Drug-Eluting Stents (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Global: Drug-Eluting Stents (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Global: Drug-Eluting Stents (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: North America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: North America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United States: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United States: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Canada: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Canada: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Asia-Pacific: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Asia-Pacific: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: China: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: China: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Japan: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Japan: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: India: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: India: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: South Korea: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: South Korea: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Australia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Australia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Indonesia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Indonesia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Europe: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Europe: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Germany: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Germany: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: France: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: France: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: United Kingdom: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: United Kingdom: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Italy: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Italy: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Spain: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Spain: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Russia: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Russia: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Latin America: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Latin America: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Brazil: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Brazil: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Mexico: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Mexico: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 99: Others: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 100: Others: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Middle East and Africa: Drug-Eluting Stents Market: Sales Value (in Million US$), 2016 & 2021
Figure 102: Middle East and Africa: Drug-Eluting Stents Market: Breakup by Country (in %), 2021
Figure 103: Middle East and Africa: Drug-Eluting Stents Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 104: Global: Drug-Eluting Stents Industry: SWOT Analysis
Figure 105: Global: Drug-Eluting Stents Industry: Value Chain Analysis
Figure 106: Global: Drug-Eluting Stents Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Drug-Eluting Stents Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Drug-Eluting Stents Market Forecast: Breakup by Coating (in Million US$), 2022-2027
Table 3: Global: Drug-Eluting Stents Market Forecast: Breakup by Drug (in Million US$), 2022-2027
Table 4: Global: Drug-Eluting Stents Market Forecast: Breakup by Stent Platform (in Million US$), 2022-2027
Table 5: Global: Drug-Eluting Stents Market Forecast: Breakup by Generation (in Million US$), 2022-2027
Table 6: Global: Drug-Eluting Stents Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 7: Global: Drug-Eluting Stents Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 8: Global: Drug-Eluting Stents Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Drug-Eluting Stents Market: Competitive Structure
Table 10: Global: Drug-Eluting Stents Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Peripheral Vascular Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Operating Room Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Intraoperative Neuromonitoring (IONM) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Neurology Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links